These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 22079422)

  • 1. [From HLA to cell therapy].
    Charron D
    Rev Med Interne; 2012 Jan; 33(1):62-3. PubMed ID: 22079422
    [No Abstract]   [Full Text] [Related]  

  • 2. Rapid generation of Epstein-Barr virus-specific T cells for cellular therapy.
    Hao QF; Yang YX; Wang Y; Chen LM; Sheng GY; Luan Z
    Transplant Proc; 2014; 46(1):21-5. PubMed ID: 24507020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Heterogeneity of HLA-Bw-35 and HLA-B12 antigens demonstrated by complex sera of anti-HLA-Bw4 and anti-HLA-Bw6].
    Májský A
    Vnitr Lek; 1984 May; 30(5):497-501. PubMed ID: 6331682
    [No Abstract]   [Full Text] [Related]  

  • 4. HLA class-II restriction of antigen-specific T-cell activation. With special reference to the fine specificity and immunoregulation of HLA class-II restriction elements.
    Qvigstad E; Scott H; Thorsby E
    Prog Allergy; 1985; 36():73-94. PubMed ID: 3881783
    [No Abstract]   [Full Text] [Related]  

  • 5. Generating an iPSC bank for HLA-matched tissue transplantation based on known donor and recipient HLA types.
    Taylor CJ; Peacock S; Chaudhry AN; Bradley JA; Bolton EM
    Cell Stem Cell; 2012 Aug; 11(2):147-52. PubMed ID: 22862941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mismatching for HLA-A, -B antigens and renal graft survival.
    Middleton D; Hamilton P; Doherty CC; Douglas JF; McGeown MG
    Clin Nephrol; 1985 Jan; 23(1):26-7. PubMed ID: 3884200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLA-mismatched family donor transplants: a novel strategy as curative therapy for patients with hematologic disorders.
    McGuirk JP; Seropian S; Cooper D
    Cancer J Sci Am; 1998; 4(5):278-86. PubMed ID: 9815289
    [No Abstract]   [Full Text] [Related]  

  • 8. [Do we have a sufficient supply of anti-HLA serum? Review of sera produced by the transfusion service 1974-1992].
    Májský A
    Vnitr Lek; 1993 Sep; 39(9):883-6. PubMed ID: 8212642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Serologic properties of antigens HLA-A, B and C].
    Perreault C
    Can Med Assoc J; 1981 Mar; 124(6):690-7. PubMed ID: 7008927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The present incidence of HLA-B and C antigens and certain cross reacting HLA-A and B antigens. Frequency of incidence in Czechoslovakia].
    Májský A
    Vnitr Lek; 1984 Feb; 30(2):144-6. PubMed ID: 6586008
    [No Abstract]   [Full Text] [Related]  

  • 11. The role of the laboratory in rheumatology. HLA antigens.
    Dewar PJ
    Clin Rheum Dis; 1983 Apr; 9(1):93-116. PubMed ID: 6575884
    [No Abstract]   [Full Text] [Related]  

  • 12. [Alloantigens--tissue structures determining the level of body sensitivity to pathogenic factors].
    Shabalin VN; Serova LD
    Vestn Akad Med Nauk SSSR; 1984; (1):68-75. PubMed ID: 6201021
    [No Abstract]   [Full Text] [Related]  

  • 13. HLA-G: a new opening for HLA.
    Dausset J; Carosella ED
    Semin Cancer Biol; 1999 Feb; 9(1):1. PubMed ID: 10092544
    [No Abstract]   [Full Text] [Related]  

  • 14. The HLA system in rheumatoid arthritis.
    Panayi GS
    Eur J Rheumatol Inflamm; 1982; 5(4):423-4. PubMed ID: 6983961
    [No Abstract]   [Full Text] [Related]  

  • 15. [The significance of HLA antigens and HLA antibodies in the integrated dialysis and transplantation program].
    Erbenová E; Erben J
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove Suppl; 1981; 24(1):7-39. PubMed ID: 7031866
    [No Abstract]   [Full Text] [Related]  

  • 16. [Changes in the detectability of HLA antigens on lymphocyte subpopulations induced by mitogens and corticosteroids].
    Volgin AIu; Pevnitskiĭ LA
    Biull Eksp Biol Med; 1982 Jan; 93(1):45-7. PubMed ID: 6978158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Seronegative ("reactive") arthritis; bacterial cell envelope antigens with cross reactions against HLA-B27].
    van Bohemen CG; Nabbe AJ; Goei The HS; van Alphen L; Zanen HC
    Ned Tijdschr Geneeskd; 1985 May; 129(19):882-6. PubMed ID: 3874370
    [No Abstract]   [Full Text] [Related]  

  • 18. HLA class II antigens and the human thyroid cell: a review.
    Davies TF; Piccinini LA
    Mt Sinai J Med; 1986 Jan; 53(1):23-30. PubMed ID: 3512982
    [No Abstract]   [Full Text] [Related]  

  • 19. HLA and schistosomiasis japonica.
    Wang CG; Zhu QY; Hang PY; Zhu YW; Wang JW; Shen YP; Yang SJ; Chao JY
    Chin Med J (Engl); 1984 Aug; 97(8):603-5. PubMed ID: 6440750
    [No Abstract]   [Full Text] [Related]  

  • 20. A review: HLA and diseases--current status.
    Buc M; Stefanovic J
    J Hyg Epidemiol Microbiol Immunol; 1989; 33(3):357-65. PubMed ID: 2681404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.